XML 63 R45.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
SCHEDULE OF STOCK OPTION ACTIVITIES (Details) - USD ($)
 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Weighted average exercise price, ending outstanding $ 2.3  
Equity Option [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of options, beginning outstanding 1,264,890 1,235,192
Weighted average exercise price, beginning outstanding $ 9.29 $ 14.08
Weighted average remaining contractual term beginning outstanding 6 years 3 months 18 days 5 years 9 months
Aggregate intrinsic value, beginning outstanding [1] $ 8,185,321 [2] $ 567,694
Number of options, beginning outstanding 12,655  
Weighted average exercise price, beginning outstanding  
Number of options, granted 7,210 285,657
Weighted average exercise price, granted $ 2.77 $ 6.60
Weighted average remaining contractual term granted 9 years 3 days 9 years 11 months 12 days
Number of options, exercised   (374)
Weighted average exercise price, exercised   $ 4.44
Number of options, expired (39,520) (222,331)
Weighted average exercise price, expired $ 3.89 $ 30.69
Weighted average remaining contractual term expired 3 years 9 months 3 days 4 years 9 months 29 days
Number of options, forfeited (5,362) (33,254)
Weighted average exercise price, forfeited $ 12.30 $ 6.50
Weighted average remaining contractual term forfeited 8 years 10 months 6 days 6 years 10 months 9 days
Number of options, ending outstanding 1,239,873 1,264,890
Weighted average exercise price, ending outstanding $ 9.39 $ 9.29
Weighted average remaining contractual term ending outstanding 5 years 4 months 6 days 6 years 3 months 18 days
Aggregate intrinsic value, ending outstanding [2] $ 9,705,937 $ 8,185,321 [1]
Number of options vested and expected to vest 1,239,873 1,264,890
Weighted average exercise price vested and expected to vest $ 9.32 $ 9.29
Weighted average remaining contractual term vested and expected to vest 5 years 4 months 6 days 6 years 3 months 18 days
Aggregate intrinsic value vested and expected to vest $ 9,806,024 [2] $ 8,185,321 [1]
Number of options vested and exercisable 1,134,642 960,521
Weighted average exercise price vested and exercisable $ 9.62 $ 10.10
Weighted average remaining contractual term vested and exercisable 5 years 1 month 6 days 5 years 6 months 14 days
Aggregate intrinsic value vested and exercisable $ 9,320,582 [2] $ 1,165,124 [1]
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of our common stock as of March 31, 2023 and fair value of common stock adjusted for the Reverse Split as of March 31, 2022 of $2.81 and $13.62 per share, respectively.
[2] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value of our common stock as of March 31, 2024 and fair value of common stock adjusted for the Reverse Split as of March 31, 2023 of $1.48 and $2.81 per share, respectively.